Check nearby libraries
Buy this book
![Loading indicator](/images/ajax-loader-bar.gif)
"This book is about benefit and risk. More precisely, this book is about the definition, assessment, balance and communication of favorable and unfavorable consequences of treatments in pharmaceutical research and development. This book is not a definitive treatise on benefit and risk in pharmaceutical research and development. It is not a prescriptive guide for characterizing the benefits and risks of a molecule under development. Nor is it a collection of best practices and recommendations for a successful benefit and risk assessment. It is a gateway. It is a gateway that opens into a long corridor that chronicles the concepts, assessment methods, interpretations and implications of benefits and risks as a molecule journeys from concept to customer. Along the corridor are four doors that open into four galleries. Depending upon our experiences and state of mind, these doors may appear dark and foreboding, etched with esoteric runes and rubbed with mystic herbs ... or curious and unusual entryways we've walked by for years yet never thought to enter ... or enticing and accessible points of access to newly revealed vistas abundant with challenge and promise. Each door in the corridor will bear one of four brass plates: Early Clinical Development, Full Clinical Development, Regulatory Review and Policy, Post Launch Assessment. In the Early Clinical Development gallery, we will encounter interpretations of benefit and risk in the context of a molecule moving from discovery through its preclinical evaluation and its initial testing in man. The Full Clinical Development door opens into a gallery that considers benefit and risk during a molecule's journey from its entry into man until it is submitted to regulators for approval"--
Check nearby libraries
Buy this book
![Loading indicator](/images/ajax-loader-bar.gif)
Subjects
Drugs, Testing, Pharmacoepidemiology, Health risk assessment, MATHEMATICS / Probability & Statistics / General, MEDICAL / Pharmacology, Drugs, research, Risk assessment, Pharmacology, Statistics, Pharmaceutical industry, Clinical Trials as Topic, Health Status Indicators, Médicaments, Essais cliniques, Pharmacoépidémiologie, Risques pour la santé, Évaluation, MEDICAL, Drug Evaluation, Methods, MATHEMATICS, Probability & Statistics, GeneralShowing 2 featured editions. View all 2 editions?
Edition | Availability |
---|---|
1
Benefit-Risk Assessment in Pharmaceutical Research and Development
2020, Taylor & Francis Group
in English
0367576244 9780367576240
|
zzzz
Libraries near you:
WorldCat
|
2
BenefitRisk Assessment in Pharmaceutical Research and Development
2013, Taylor & Francis Ltd
1439867941 9781439867945
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Classifications
ID Numbers
Community Reviews (0)
Feedback?August 8, 2024 | Edited by MARC Bot | import existing book |
December 15, 2022 | Edited by MARC Bot | import existing book |
September 21, 2021 | Edited by ImportBot | import existing book |
September 18, 2021 | Edited by ImportBot | import existing book |
October 19, 2016 | Created by Mek | Added new book. |